Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor–Based Combination Antiretroviral Therapy

As the nature of viral blips remains unclear, their occurrence often leads to uncertainty. This study compares blip incidence rates during treatment with different combination antiretroviral therapy anchors. Retrospective cohort study in a tertiary hospital. All antiretroviral regimens between 2010...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2022-04, Vol.89 (5), p.575-582
Hauptverfasser:	Dijkstra, Suzan, Hofstra, L. Marije, Mudrikova, Tania, Wensing, Annemarie M. J., Oomen, Patrick G. A., Hoepelman, Andy I. M., van Welzen, Berend J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiretroviral Therapy, Highly Active - adverse effects Confidence intervals Drug therapy Evaluation Failure HIV HIV Infections - complications HIV Integrase Inhibitors - therapeutic use HIV Seropositivity - complications HIV-1 Human immunodeficiency virus Humans Incidence Integrase Non-nucleoside reverse transcriptase inhibitors Protease inhibitors Proteinase inhibitors Retrospective Studies Reverse Transcriptase Inhibitors - therapeutic use RNA-directed DNA polymerase Therapy Viral Load Viremia Viremia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!